Prevalence of CVC-associated Sepsis and Use of Blood Cultures in Berlin - Brandenburg
Structured web-based survey in selected hospitals with intensive care units in Berlin- Brandenburg to collect data on the overall number of blood cultures (used) and the prevalence of (positive blood cultures in patients with) CVC - associated sepsis.
|Study Design:||Observational Model: Cohort
Time Perspective: Retrospective
|Official Title:||Retrospective Analysis of Proven Bacteremia, CVC-associated Infections and Sepsis|
- Total number of blood cultures drawn and total number of positive findings in ICUs [ Time Frame: 1 year ] [ Designated as safety issue: No ]Retrospective analysis of cases with positive bloodculture among patients in ICU setting compared to the total amount of blood cultures taken in the same period of time and same hospital.
- Prevalence on CVC - associated sepsis/CLABSIs [ Time Frame: 1 year ] [ Designated as safety issue: No ]
|Study Start Date:||July 2011|
|Estimated Study Completion Date:||October 2014|
|Estimated Primary Completion Date:||October 2014 (Final data collection date for primary outcome measure)|
Participating hospitals in the INABBRA alliance.
The use of CVC represents one of the major risk factors for sepsis, a highly prevalent disease in ICUs. Blood cultures obtained prior to antibiotic administration are part of the SSC Resuscitation Bundle and essential for the outcome of the patient. The CDC criteria to diagnose sepsis do not take into account the overall number of blood cultures obtained and thus, lead to an underestimation of the true incidence of sepsis. Up to now, few data is available on the total number of blood cultures obtained and the relation to the incidence of sepsis in German ICUs.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01388686
|Contact: Claudia Spies, MD, Prof.||+49 30 450 email@example.com|
|Department of Anesthesiology and Intensive Care Medicine, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitaetsmedizin Berlin||Recruiting|
|Berlin, Germany, 13353|
|Contact: Claudia Spies, MD, Prof. +49 30 450 551001 firstname.lastname@example.org|
|Sub-Investigator: Maria Deja, MD , PD|
|Sub-Investigator: Irit Nachtigall, MD, Dr.|
|Sub-Investigator: Andreas Rothbart, MD, Dr.|
|Study Director:||Claudia Spies, MD, Prof.||Department of Anesthesiology and Intensive Care Medicine, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitaetsmedizin Berlin|